Brookings conference on post-market safety
Executive Summary
Brookings Institution's Engelberg Center for Health Care Reform will hold a conference in Washington, D.C., June 13 on drug safety and post-market evidence, hosted by center Director Mark McClellan. During the conference, FDA Commissioner Andrew von Eschenbach and CDER Director Janet Woodcock are scheduled to discuss the agency's new Sentinel initiative, along with Richard Platt, Harvard University, Marcus Wilson, from WellPoint's HealthCore unit, and Janet Marchibroda, eHealth Initiative. Some details on the Sentinel project were announced by FDA May 22. Other conference participants will include Garry Neil, J&J, and Arnold Chan, i3 Drug Safety
You may also be interested in...
Building the Right Foundation: An Interview with Mark McClellan
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.